StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP – Get Free Report) in a research report issued to clients and investors on Sunday. The brokerage set a “hold” rating on ...

The Vatican said that Pope Francis’ health had deteriorated over the past 24 hours and for the first time described his ...

Local companies are developing technologies that they hope could replace a painful poke with something that feels more like ...

Micah Paul Adkins, 34, Indianapolis; arrested on charges of possession of paraphernalia, visiting a common ...

The global Insulin Delivery Devices Market was valued at USD 30.9 billion in 2022 and is expected to grow significantly, ...

Johnson & Johnson and partner Sanofi will stop a late-stage trial of an experimental vaccine to prevent infections caused by ...

This surge comes despite a recent survey showing that a staggering 73 per cent of men have never been tested for HIV. The ...

Johnson & Johnson said on Thursday it will discontinue a late-stage study of an experimental E.coli vaccine it was developing ...

Asia Pacific medical device market will grow by 8.4% annually with a total addressable market cap of $2.06 trillion over 2023-2032, driven by the prevalence of infectious diseases as well as the ...

Compounded weight-loss medications such as those promoted in the Hims & Hers commercial aren’t approved by the Food and Drug ...

The pen needles market valued at US$ 1.69 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 1.81 Billion in 2024 ...